7:00am |
Registration and Continental Breakfast
|
8:00am |
Welcome
Arun D. Singh, MD |
Session I: Retinoblastoma
|
8:15 am |
Retinoblastoma Staging: What is the standard?
Claudine Bellerive, MD |
8:30 am |
Evolution of Retinoblastoma Treatment: Are we there yet?
Arun D. Singh, MD |
8:45 am |
Retinoblastoma Pathology: Does it matter?
Gabrielle Yeaney, MD |
9:00 am |
Guest Lecture
IAC: Current Status
Matthew Wilson, MD |
9:30 am |
IVC: When to use?
Yehonatan Weinberger, MD |
9:45 am |
COG Trials
Stacey Zahler, DO |
10:00 am |
RB Genetics: New Insights
Andrew Stacey, MD |
10:15 am |
RB Biomarks are here to stay
Jesse Berry, MD |
10:30 am |
Break
|
Session II: Ocular Surface Tumors
|
11:00 am |
Guest Lecture
Ocular Surface Tumors: Which drop to use
R. Chris Bowen |
11:30 am |
Conjunctival melanocytic tumors :Pathologic Perspective
Tatyana Milman, MD |
11:45 am |
Conjunctival melanoma:How to Manage
Hakan Demirci, MD |
|
Session III: Orbital tumors
|
12:00 pm |
Guest Lecture
Transorbital Surgery
Bhupinder Patel, MD |
12:30 pm |
Lunch
|
Session IV: Uveal Melanoma
|
1:30 pm |
Iris melanoma: Diagnostic Predictive Model
Arun D. Singh, MD |
1:45 pm |
Small choroidal melanoma: Diagnostic Predictive Models
Arun D. Singh, MD |
2:00 pm |
Machine Learning and AI Methods
Emily Zabor, MD |
2:15 pm |
Small Choroidal Melanoma: Can AI do the trick?
Michael Heiferman, MD |
2:30 pm |
Guest Lecture
Andrew Schachat, MD Distinguished Lecture in Ocular Oncology Uveal Melanoma: Causation and progression
Hans Grossniklaus, MD |
3:00 pm |
Break
|
3:30 pm |
Guest Lecture
Radiation for Uveal Melanoma: Lower Dose?
Jose Echegaray, MD |
4:00 pm |
Radiation Retinopathy: Protocol AL
John Minturn, MD |
4:15 pm |
Liver Mets: Surveillance: Does it make sense?
Adrienne Delaney, MD |
4:30 pm |
Liver Mets: Current Status
Thach-Giao Truong, MD |
4:45 pm |
Liver Mets: Trial Update
James Isaacs, MD |
5:00 pm |
Saturday Adjourn
|
